Wednesday, August 19, 2015

Drug-maker Amgen will pay out $71 million for making unsupported claims to promote off-label use of anemia drug Aranesp, and severe plaque psoriasis drug Enbrel, Time reports.

http://www.medpagetoday.com/OBGYN/GeneralOBGYN/53131?isalert=1&uun=g649657d4448R5784224u&xid=NL_breakingnews_2015-08-19

No comments: